Evaluation of topotecan and etoposide for non-Hodgkin lymphoma: correlation of topoisomerase-DNA complex formation with clinical response.

Evaluation of topotecan and etoposide for non-Hodgkin lymphoma: correlation of topoisomerase-DNA complex formation with clinical response.

Item
http://www.wikidata.org/entity/Q31911584
Discovering hidden connections among diseases, genes and drugs based on microarray expression profiles with negative-term filteringPhase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study.Phase II study of 9-aminocamptothecin in previously treated lymphomas: results of Cancer and Leukemia Group B 9551.Activity of topotecan 21-day infusion in patients with previously treated large cell lymphoma: long-term follow-up of an Eastern Cooperative Oncology Group study (E5493).Reduction of atherosclerotic lesions in rabbits treated with etoposide associated with cholesterol-rich nanoemulsions.Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumoursTreatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels.Curcumin as a DNA topoisomerase II poison.In vivo bioassay to detect irinotecan-stabilized DNA/topoisomerase I complexes in rats.
P2860

Evaluation of topotecan and etoposide for non-Hodgkin lymphoma: correlation of topoisomerase-DNA complex formation with clinical response.

Item
http://www.wikidata.org/entity/Q31911584
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Evaluation of topotecan and et ...... mation with clinical response.
@ast
Evaluation of topotecan and et ...... mation with clinical response.
@en
type
label
Evaluation of topotecan and et ...... mation with clinical response.
@ast
Evaluation of topotecan and et ...... mation with clinical response.
@en
prefLabel
Evaluation of topotecan and et ...... mation with clinical response.
@ast
Evaluation of topotecan and et ...... mation with clinical response.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Evaluation of topotecan and et ...... mation with clinical response.
@en
P2093
P2860
P304
P31
P356
10.1002/1097-0142(20010201)91:3<463::AID-CNCR1023>3.0.CO;2-R
P407
P433
P478
P577
P698